根管内支架对再生牙髓治疗成功率影响的系统评价与网状Meta分析
该系统评价与网状Meta分析比较了不同根管内支架对再生牙髓治疗(RET)成功结局的影响,纳入27项随访至少12个月的研究。结果显示,富血小板血浆(PRP)、血凝块(BC)和富血小板纤维蛋白(PRF)支架的临床成功率范围分别为91.66%-100%、84.61%-100%和77%-100%,不同支架在临床成功、牙根成熟和牙髓感觉方面均无统计学显著差异。
要点
- 不同根管内支架在RET临床成功率上无统计学显著差异(PRF vs BC P=1.000,PRP vs BC P=1.000,PRF vs PRP P=.999)。
- PRP、BC和PRF支架的临床成功率范围分别为91.66%-100%、84.61%-100%和77%-100%。
- 不同支架在根尖闭合和牙髓感觉方面亦无统计学显著差异。
核心结论
- RET中使用的根管内支架在临床成功、牙根成熟和牙髓感觉方面未导致显著差异。
研究设计与样本
- 系统评价与网状Meta分析,检索PubMed/Medline、EMBASE、Cochrane、CINAHL、Scopus和Web of Science数据库,纳入评估和/或比较不同支架RET临床和/或影像学成功且随访至少12个月的研究,共纳入27项研究。
主要发现
- 27项研究中25项偏倚风险低,2项偏倚风险中等。
- PRP、BC和PRF支架的RET临床成功率范围分别为91.66%-100%、84.61%-100%和77%-100%。
- 不同支架在临床成功方面无统计学显著差异:PRF vs BC(P=1.000),PRP vs BC(P=1.000),PRF vs PRP(P=.999)。
- 不同支架在根尖闭合方面无统计学显著差异:PRF vs BC(P=1.000),PRP vs BC(P=.835),PRF vs PRP(P=.956)。
- 不同支架在牙髓感觉方面无统计学显著差异:PRF vs BC(P=.980),PRP vs BC(P=.520),PRF vs PRP(P=.990)。
关键数值与推荐
- 纳入标准:评估和/或比较不同支架RET临床和/或影像学成功的研究,随访至少12个月。
- 偏倚风险评估使用Cochrane协作网偏倚风险工具和Joanna Briggs研究所相应工具。
- 主要结局为临床成功,其他成功结局包括牙根成熟和牙髓感觉。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The scaffolds used in regenerative endodontic therapy (RET) provide structural support for cells so that they can adhere to the scaffolds and also are crucial for cellular proliferation and differentiation. The objective of this network meta-analysis was to compare effects of different intracanal scaffolds on success outcomes of RET. METHODS: PubMed/Medline, EMBASE, Cochrane, CINAHL, Scopus, and Web of Science databases were searched. Studies evaluating and/or comparing clinical and/or radiographic success of RET using different scaffolds with a minimum of 12 months follow-up were included. The Cochrane Collaboration risk of bias (ROB) tool and appropriate tools from Joanna Briggs Institute were used for the assessment of ROB. A network meta-analysis was performed to compare the primary outcome (clinical success) and other success outcomes (root maturation, and pulpal sensibility) using different scaffolds. RESULTS: Twenty-seven studies fulfilled the desired inclusion criteria of which 25 had a low ROB whereas 2 had a moderate ROB. Clinical success of RET using platelet-rich plasma (PRP), blood clot (BC), and platelet-rich fibrin (PRF) scaffolds ranged between 91.66%-100%, 84.61%-100%, and 77%-100% respectively. The different scaffolds did not show any statistically significant difference in clinical success (PRF vs BC [P = 1.000], PRP vs BC [P = 1.000], and PRF vs PRP [P = .999]), apical root closure (PRF vs BC [P = 1.000], PRP vs BC [P = .835], PRF vs PRP [P = .956]), and pulp sensibility (PRF vs BC [P = .980], PRP versus BC [P = .520], and PRF vs PRP [P = .990]). CONCLUSION: The intracanal scaffolds used during RET did not result in significant differences in regard to clinical success, root maturation, and pulpal sensibility.
引用
- Rahul M, Lokade A, Tewari N, et al. Effect of Intracanal Scaffolds on the Success Outcomes of Regenerative Endodontic Therapy - A Systematic Review and Network Meta-analysis. J Endod. 2022. PMID: 36410623. doi:10.1016/j.joen.2022.11.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。